• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses.

作者信息

Nyambi P N, Nkengasong J, Peeters M, Simon F, Eberle J, Janssens W, Fransen K, Willems B, Vereecken K, Heyndrickx L

机构信息

Institute of Tropical Medicine, Antwerp, Belgium.

出版信息

J Infect Dis. 1995 Nov;172(5):1228-37. doi: 10.1093/infdis/172.5.1228.

DOI:10.1093/infdis/172.5.1228
PMID:7594658
Abstract

Neutralizing antibody patterns in sera of persons infected with human immunodeficiency virus type 1 (HIV-1) groups M and O to their homologous and heterologous primary isolates were determined in a peripheral blood mononuclear cell-based neutralization assay and correlated with their ability to bind to V3 loop synthetic peptides. Most HIV-1 group M sera (9/16) neutralized HIV-1 group O viruses, whereas fewer group O sera (3/13) only weakly neutralized HIV-1 group M viruses. Group M sera neutralizing HIV-1 group O viruses neutralized other HIV-1 group M viruses with titers of 1:10-1:1280. V3 loop binding capacity of sera did not reflect their neutralizing capacity of the homologous isolate. Despite the reduced neutralizing capacity of group O-infected patients' sera to group M viruses, some group M-infected patients' sera neutralized both HIV-1 group M and O isolates, suggesting that they share some conserved neutralizing epitopes.

摘要

相似文献

1
Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses.
J Infect Dis. 1995 Nov;172(5):1228-37. doi: 10.1093/infdis/172.5.1228.
2
Cross-neutralizing antibodies to HIV-1ANT70 and HIV-1IIIB in sera of African and Belgian HIV-1-infected individuals.
AIDS. 1994 Aug;8(8):1089-96. doi: 10.1097/00002030-199408000-00008.
3
Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.赤道几内亚1型O组HIV分离株的包膜序列变异性和血清学特征
AIDS Res Hum Retroviruses. 1997 Aug 10;13(12):995-1005. doi: 10.1089/aid.1997.13.995.
4
A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response.可变区3(V3)突变决定了一种与广泛交叉反应的原发性病毒中和抗体反应相关的人类免疫缺陷病毒1型包膜的整体中和表型和不依赖CD4的感染性。
J Virol. 2002 Jan;76(2):644-55. doi: 10.1128/jvi.76.2.644-655.2002.
5
Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.1型人类免疫缺陷病毒ADA株gp120单体与gp140三聚体作为诱导中和抗体免疫原的比较
AIDS Res Hum Retroviruses. 2005 Jan;21(1):58-67. doi: 10.1089/aid.2005.21.58.
6
V3-specific polyclonal antibodies affinity purified from sera of infected humans effectively neutralize primary isolates of human immunodeficiency virus type 1.从受感染人类血清中亲和纯化的V3特异性多克隆抗体可有效中和1型人类免疫缺陷病毒的原始分离株。
AIDS Res Hum Retroviruses. 2001 Dec 10;17(18):1737-48. doi: 10.1089/08892220152741432.
7
Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking.对人类免疫缺陷病毒1型A亚型和B亚型V3结构域具有交叉反应性的抗体在喀麦隆患者血清中很常见,但其中和活性通常受到表位掩盖的限制。
J Virol. 2005 Jan;79(2):780-90. doi: 10.1128/JVI.79.2.780-790.2005.
8
Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.人类免疫缺陷病毒的嵌合gag-V3病毒样颗粒可诱导病毒中和抗体。
Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10527-31. doi: 10.1073/pnas.89.21.10527.
9
Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants.在选定佐剂中,对1型人类免疫缺陷病毒原代分离株三聚体和单体包膜糖蛋白引发的抗体反应的表征。
J Virol. 2006 Feb;80(3):1414-26. doi: 10.1128/JVI.80.3.1414-1426.2006.
10
Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies.将1型人类免疫缺陷病毒(HIV-1)LAI的主要合胞体诱导(SI)和非SI包膜V3环插入后,会降低其对自身HIV-1抗体的中和敏感性,但不会降低对异源HIV-1抗体的中和敏感性。
J Virol. 1995 Oct;69(10):6342-51. doi: 10.1128/JVI.69.10.6342-6351.1995.

引用本文的文献

1
V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1.V1/V2中和表位在不同的HIV-1非M组中保守。
J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):237-45. doi: 10.1097/QAI.0000000000000854.
2
Longitudinal study of primary HIV-1 isolates in drug-naïve individuals reveals the emergence of variants sensitive to anti-HIV-1 monoclonal antibodies.在未接受药物治疗的个体中对原发性 HIV-1 分离物进行的纵向研究显示出对抗 HIV-1 单克隆抗体敏感的变异体的出现。
PLoS One. 2011 Feb 23;6(2):e17253. doi: 10.1371/journal.pone.0017253.
3
Structural conservation predominates over sequence variability in the crown of HIV type 1's V3 loop.
在1型人类免疫缺陷病毒V3环顶端,结构保守性比序列变异性更为显著。
AIDS Res Hum Retroviruses. 2010 Jun;26(6):717-23. doi: 10.1089/aid.2009.0254.
4
Neutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naive individuals.HIV-1 B亚型感染的初治个体中HIV-1包膜序列的中和模式及序列演变
AIDS Res Hum Retroviruses. 2008 Dec;24(12):1507-19. doi: 10.1089/aid.2008.0154.
5
Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic clades.可溶性CD4对不同基因分支的原发性、完整、天然1型人类免疫缺陷病毒颗粒表位暴露的影响。
J Virol. 2001 Aug;75(16):7785-8. doi: 10.1128/JVI.75.16.7785-7788.2001.
6
Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.1型人类免疫缺陷病毒(HIV-1)完整病毒体的免疫反应性表明,HIV-1免疫型的数量少于基因型。
J Virol. 2000 Nov;74(22):10670-80. doi: 10.1128/jvi.74.22.10670-10680.2000.
7
Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.M组完整、天然、原代人类免疫缺陷病毒1型病毒体上保守且暴露的表位。
J Virol. 2000 Aug;74(15):7096-107. doi: 10.1128/jvi.74.15.7096-7107.2000.
8
Discrimination of subtype B and non-subtype B strains of human immunodeficiency virus type 1 by serotyping: correlation with genotyping.通过血清分型鉴别1型人类免疫缺陷病毒的B亚型和非B亚型毒株:与基因分型的相关性
J Clin Microbiol. 1999 May;37(5):1356-60. doi: 10.1128/JCM.37.5.1356-1360.1999.
9
Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIV.1型人类免疫缺陷病毒(HIV)的免疫分型:一种HIV免疫分类方法
J Virol. 1999 May;73(5):4042-51. doi: 10.1128/JVI.73.5.4042-4051.1999.
10
Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1.完整的1型人类免疫缺陷病毒(HIV-1)病毒粒子上暴露表位的定位:一种研究HIV-1免疫相关性的新策略。
J Virol. 1998 Nov;72(11):9384-91. doi: 10.1128/JVI.72.11.9384-9391.1998.